Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Timber Pharmaceuticals Inc. - news published 105 - readings 1.051

BACK

Timber Pharmaceuticals Inc.

Material Event - Form 8-K

The text version of this document is not available. You can access the original document here . Attachments Original Link Original Document Permalink Disclaimer Timber Pharmaceuticals Inc. published this content on 22 February 2024 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 22 February 2024 15:54:04 UTC . ...

22.02.2024

Timber Pharmaceuticals Inc.

Material Event - Form 8-K

The text version of this document is not available. You can access the original document here . Attachments Original Link Original Document Permalink Disclaimer Timber Pharmaceuticals Inc. published this content on 26 January 2024 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 26 January 2024 13:03:12 UTC .

26.01.2024

Timber Pharmaceuticals Inc.

Acquisition/Asset Disposal - Form 8-K

Item 1.01 Entry into a Material Definitive Agreement. The information set forth below in Item 2.01 in this Current Report on Form 8-K is hereby incorporated by reference into this Item 1.01. Attachments Original Link Original Document Permalink Disclaimer Timber Pharmaceuticals Inc. published this content on 23 January 2024 and is solely responsible for the information contain ...

23.01.2024

Timber Pharmaceuticals Inc.

Material Event - Form 8-K

The text version of this document is not available. You can access the original document here . Attachments Original Link Original Document Permalink Disclaimer Timber Pharmaceuticals Inc. published this content on 22 December 2023 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 22 December 2023 21:14:07 UTC . ...

22.12.2023

Timber Pharmaceuticals Inc.

Timber Pharmaceuticals Receives Court Approval of All "First Day" Motions to Support Business Operations & Discloses Communication From NYSE American

Seelos Therapeutics Announces Proposed Public Offering NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it has commenced an underwritten public offering of shares of ...

28.11.2023

Timber Pharmaceuticals Inc.

D.I. 15 & 53 - Form 8-K

Re: D.I. 15 & 53 INTERIM ORDER APPROVING NOTIFICATION AND HEARING PROCEDURES FOR (I) CERTAIN TRANSFERS OF AND DECLARATIONS OF WORTHLESSNESS WITH RESPECT TO COMMON STOCK, (II) CERTAIN TRANSFERS OF CLAIMS AGAINST DEBTORS AND (III) GRANTING RELATED RELIEF Upon consideration of the motion (the " Motion "), 2 of the above-captioned debtors and debtors in possession (c ...

28.11.2023

Timber Pharmaceuticals Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Item 1.01 Entry into a Material Definitive Agreement. The information set forth below in Item 1.03 and Item 2.03 in this Current Report on Form 8-K under the captions " LEO Stalking Horse APA " and " Debtor-in-Possession Financing ", respectively, are hereby incorporated by reference into this Item 1.01. Attachments Original Link Original Document Permalink ...

17.11.2023

Timber Pharmaceuticals Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Item 5.07. Submission of Matters to a Vote of Security Holders On November 17, 2023, Timber Pharmaceuticals, Inc. (the "Company") held its Special Meeting of Stockholders (the "Special Meeting"). The matters voted on at the Special Meeting were: (1) to adopt the Agreement and Plan of Merger (the "Merger Agreement") with LEO US Holding, Inc., a Del ...

17.11.2023

Timber Pharmaceuticals Inc.

Late Filing Notice - Form NT 10-Q

tmbr20231109_nt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on ...

15.11.2023

Timber Pharmaceuticals Inc.

Additional Proxy Soliciting Materials - Form DEFA14A

tmbr20231028_defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as p ...

31.10.2023

Timber Pharmaceuticals Inc.

Material Agreement - Form 425

Item 1.01 Entry into a Material Definitive Agreement. As previously disclosed, on August 20, 2023, Timber Pharmaceuticals, Inc. ("Timber" or the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement") with LEO US Holding, Inc., ("Parent"), LEO Spiny Merger Sub, Inc., ("Merger Sub") and LEO Pharma A/S, ...

30.10.2023

Timber Pharmaceuticals Inc.

Material Agreement - Form 8-K

30.10.2023

Timber Pharmaceuticals Inc.

Submission of Matters to a Vote of Security Holders - Form 425

Item 5.07. Submission of Matters to a Vote of Security Holders On October 16, 2023, Timber Pharmaceuticals, Inc. (the "Company" or "Timber") convened and then adjourned its 2023 Special Meeting of Stockholders (the "Special Meeting") being held to consider and vote on the following proposals: (1) the adoption of the Agreement and Plan of Merger, d ...

16.10.2023

Timber Pharmaceuticals Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

16.10.2023

Timber Pharmaceuticals Inc.

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance - Form 8-K

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance WARREN, NJ, September 18, 2023 - Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today annou ...

18.09.2023

Timber Pharmaceuticals Inc. - news published 105 - readings 1.051

Timber Pharmaceuticals Inc.

Material Event - Form 8-K

Timber Pharmaceuticals Inc.

Material Event - Form 8-K

Timber Pharmaceuticals Inc.

Acquisition/Asset Disposal - Form 8-K

Timber Pharmaceuticals Inc.

Material Event - Form 8-K

Timber Pharmaceuticals Inc.

Timber Pharmaceuticals Receives Court Approval of All "First Day" Motions to Support Business Operations & Discloses Communication From NYSE American

Timber Pharmaceuticals Inc.

D.I. 15 & 53 - Form 8-K

Timber Pharmaceuticals Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Timber Pharmaceuticals Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Timber Pharmaceuticals Inc.

Late Filing Notice - Form NT 10-Q

Timber Pharmaceuticals Inc.

Additional Proxy Soliciting Materials - Form DEFA14A

Timber Pharmaceuticals Inc.

Material Agreement - Form 425

Timber Pharmaceuticals Inc.

Material Agreement - Form 8-K

Timber Pharmaceuticals Inc.

Submission of Matters to a Vote of Security Holders - Form 425

Timber Pharmaceuticals Inc.

Submission of Matters to a Vote of Security Holders - Form 8-K

Timber Pharmaceuticals Inc.

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance - Form 8-K

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member